MedPath

Effect of vitamin E in out come of IVF

Phase 2
Conditions
-Unexplained infertility.
Female Iinfertility, Unspecified
Registration Number
IRCT201405286541N4
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Exclusion criteria:
Normal semen sample ?
Normal Hystrosalpin geography ?
Normal ovulation?
IVF For ferst time ?
Long protocole?
Befor 39 years old ?

No desire for cooperation ?
Sensivity to Vitamin E ?
= 39 year old ?

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-Quality and number of ovum and emberyo have received in each IVF cycle. Timepoint: -On day of ovum pick up and emberyo insercion (IVF). Method of measurement: -Measuring number and quality of ovumes on the day of pick up in lab by pathologist under microscope (GV , MI , MII ) and quality of emberyo also by the same pathologist due to kind of cell division ( Grade I , II , III , IV).
Secondary Outcome Measures
NameTimeMethod
Clinical pregnancy or misscariage. Timepoint: 4 – 6 weeks after emberyo transfering. Method of measurement: Serum BHCG and TVS.
© Copyright 2025. All Rights Reserved by MedPath